Aaron Wealth Advisors LLC Raises Stock Position in Aflac Incorporated (NYSE:AFL)
by Jessica Moore · The Cerbat GemAaron Wealth Advisors LLC boosted its stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 12.3% during the 1st quarter, Holdings Channel reports. The firm owned 4,170 shares of the financial services provider’s stock after acquiring an additional 456 shares during the quarter. Aaron Wealth Advisors LLC’s holdings in Aflac were worth $464,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently bought and sold shares of the company. Phillips Wealth Planners LLC boosted its holdings in Aflac by 1.5% during the first quarter. Phillips Wealth Planners LLC now owns 6,653 shares of the financial services provider’s stock worth $711,000 after buying an additional 100 shares in the last quarter. Optas LLC increased its position in Aflac by 3.5% during the first quarter. Optas LLC now owns 2,949 shares of the financial services provider’s stock worth $328,000 after purchasing an additional 101 shares during the last quarter. Family Legacy Inc. increased its position in Aflac by 4.3% during the fourth quarter. Family Legacy Inc. now owns 2,607 shares of the financial services provider’s stock worth $270,000 after purchasing an additional 107 shares during the last quarter. Ashton Thomas Private Wealth LLC increased its position in Aflac by 1.9% during the fourth quarter. Ashton Thomas Private Wealth LLC now owns 5,927 shares of the financial services provider’s stock worth $613,000 after purchasing an additional 110 shares during the last quarter. Finally, Titleist Asset Management LLC increased its position in Aflac by 3.4% during the fourth quarter. Titleist Asset Management LLC now owns 3,324 shares of the financial services provider’s stock worth $344,000 after purchasing an additional 110 shares during the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.
Aflac Price Performance
Shares of NYSE AFL opened at $103.51 on Thursday. Aflac Incorporated has a 1-year low of $88.00 and a 1-year high of $115.50. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09. The business’s fifty day moving average price is $104.41 and its two-hundred day moving average price is $105.21. The firm has a market capitalization of $55.96 billion, a PE ratio of 16.17, a P/E/G ratio of 3.27 and a beta of 0.81.
Aflac (NYSE:AFL – Get Free Report) last announced its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The firm had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. During the same period in the prior year, the business earned $1.66 EPS. The company’s quarterly revenue was down 37.5% compared to the same quarter last year. On average, research analysts expect that Aflac Incorporated will post 6.88 EPS for the current year.
Aflac Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were paid a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac’s dividend payout ratio (DPR) is presently 36.25%.
Insider Transactions at Aflac
In other news, Director Masatoshi Koide sold 37,000 shares of the firm’s stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the sale, the director directly owned 70,992 shares of the company’s stock, valued at $7,496,045.28. This trade represents a 34.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of $106.79, for a total value of $106,790.00. Following the sale, the director directly owned 26,096 shares of the company’s stock, valued at $2,786,791.84. This trade represents a 3.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 40,750 shares of company stock valued at $4,304,295 in the last three months. Corporate insiders own 0.90% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on AFL shares. Raymond James Financial cut their price objective on shares of Aflac from $115.00 to $110.00 and set an “outperform” rating on the stock in a report on Thursday, May 29th. Wells Fargo & Company lifted their target price on shares of Aflac from $102.00 to $103.00 and gave the company an “equal weight” rating in a report on Tuesday, May 6th. Barclays lifted their target price on shares of Aflac from $95.00 to $96.00 and gave the company an “underweight” rating in a report on Thursday, May 1st. UBS Group lifted their target price on shares of Aflac from $109.00 to $114.00 and gave the company a “neutral” rating in a report on Wednesday, April 2nd. Finally, Piper Sandler lifted their price objective on shares of Aflac from $118.00 to $124.00 and gave the company an “overweight” rating in a research report on Wednesday, April 2nd. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $106.50.
View Our Latest Analysis on Aflac
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Recommended Stories
- Five stocks we like better than Aflac
- 3 Monster Growth Stocks to Buy Now
- Jefferies Raises Broadcom Price Target to $315: 19% Upside Ahead
- What is the Nasdaq? Complete Overview with History
- Whiplash for Investors: AeroVironment’s Confusing Stock Signals
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- The Ultimate Trump Bump: These Gov’t Backed Stocks Are Exploding
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).